Dr. Hur has a professional interest in gastroesophageal reflux disease, Barrett’s esophagus, gastrointestinal cancer, cancer chemoprevention and eosinophilic esophagitis. His research interests include outcomes research, specifically technology assessment with a focus on decision analysis and disease modeling. He has previously been involved in developing a simulation disease model of Barrett’s Esophagus and Esophageal Cancer.
Dr. Hur’s work has been published in numerous prestigious publications, including World Journal of Gastroenterology, Gastroenterology and Cancer Epidemiology, Biomarkers & Prevention. He has received numerous awards from the National Institutes of Health as well other research foundations.
Dr. Hur received his medical degree and Master of Public Health degrees from Johns Hopkins University and completed his internal medicine residency at the Johns Hopkins Hospital in Baltimore. He completed his fellowship at the Beth Israel Deaconess Medical Center in Boston.
More articles on GI/endoscopy:
Lovelace Medical Group adds Dr. Julie Farrer: 3 things to know
Global endoscopy market to reach $9.7B by 2021: 5 key trends
The biggest challenges for GI in 2016: 3 gastroenterologists weigh in
